Synergistic combination of cannabidiol and celecoxib or 2,5-dimethylcelecoxib exerts oxidative stress-mediated cytotoxicity and mitigates glioblastoma invasiveness
Acta Biochimica Polonica · 2025
DOI: 10.3389/abp.2025.15062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Polonica, 2025. Verfasst von Anna Rybarczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Glioblastoma, Celecoxib, Oxidative Stress, Cannabidiol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu.
Abstract (Originalsprache)
Glioblastoma remains one of the most aggressive and treatment-resistant malignancies. Current treatment options, such as radio- and chemotherapy, induce oxidative stress-mediated DNA damage leading to cancer cell death, but are also neurotoxic and not efficient in long term. Our study investigated the effects of cannabidiol, celecoxib and 2,5-dimethylcelecoxib, individually and in combinations, on U-138 MG glioblastoma cell survival, oxidative stress, canonical and non-canonical Nrf2 pathway activation, cell migration and apoptosis. Using the MTT and flow cytometry assay we found that the analyzed compounds and their combinations induce dose-dependent, synergistic, and oxidative stress-related cytotoxicity, with minimal impact (at the concentrations exhibiting anti-cancer effects) on non-cancerous human astrocyte (HA) cell line. The Nrf2 ELISA assay was used for the analysis of the nuclear binding of the nuclear factor-2 erythroid related factor-2 (Nrf2), which followed by the RT-qPCR and Western blot analysis, confirmed the antioxidant response of cells to the applied treatments. Diminished migratory potential, and increase of the autophagy-related p62, LC3 and apoptosis-related caspase-3 protein levels were also observed in response to the treatment with the analyzed compounds. Overall, our study provides evidence that cannabidiol combined with celecoxib or 2,5-dimethylcelecoxib may represent a promising strategy for glioblastoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland.
- Doctoral School, Poznan University of Medical Sciences, Poznań, Poland.
Förderung
- Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
Zitieren
APA
Rybarczyk, A., Majchrzak-Celińska, A., & Krajka-Kuźniak, V. (2025). Synergistic combination of cannabidiol and celecoxib or 2,5-dimethylcelecoxib exerts oxidative stress-mediated cytotoxicity and mitigates glioblastoma invasiveness. Acta Biochimica Polonica. https://doi.org/10.3389/abp.2025.15062
Vancouver
Rybarczyk A, Majchrzak-Celińska A, Krajka-Kuźniak V. Synergistic combination of cannabidiol and celecoxib or 2,5-dimethylcelecoxib exerts oxidative stress-mediated cytotoxicity and mitigates glioblastoma invasiveness. Acta Biochimica Polonica. 2025. doi:10.3389/abp.2025.15062
BibTeX
@article{Rybarczyk2025,
author = {Rybarczyk, Anna and Majchrzak-Celińska, Aleksandra and Krajka-Kuźniak, Violetta},
title = {Synergistic combination of cannabidiol and celecoxib or 2,5-dimethylcelecoxib exerts oxidative stress-mediated cytotoxicity and mitigates glioblastoma invasiveness},
journal = {Acta Biochimica Polonica},
year = {2025},
doi = {10.3389/abp.2025.15062}
}
EUVIMED